These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

433 related items for PubMed ID: 21843636

  • 1. Stable over-expression of PPARβ/δ and PPARγ to examine receptor signaling in human HaCaT keratinocytes.
    Borland MG, Khozoie C, Albrecht PP, Zhu B, Lee C, Lahoti TS, Gonzalez FJ, Peters JM.
    Cell Signal; 2011 Dec; 23(12):2039-50. PubMed ID: 21843636
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Ligand activation of peroxisome proliferator-activated receptor-beta/delta(PPARbeta/delta) inhibits cell growth of human N/TERT-1 keratinocytes.
    Burdick AD, Bility MT, Girroir EE, Billin AN, Willson TM, Gonzalez FJ, Peters JM.
    Cell Signal; 2007 Jun; 19(6):1163-71. PubMed ID: 17254750
    [Abstract] [Full Text] [Related]

  • 5. All-trans-retinoic acid represses obesity and insulin resistance by activating both peroxisome proliferation-activated receptor beta/delta and retinoic acid receptor.
    Berry DC, Noy N.
    Mol Cell Biol; 2009 Jun; 29(12):3286-96. PubMed ID: 19364826
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Ligand-mediated regulation of peroxisome proliferator-activated receptor (PPAR) beta/delta: a comparative analysis of PPAR-selective agonists and all-trans retinoic acid.
    Rieck M, Meissner W, Ries S, Müller-Brüsselbach S, Müller R.
    Mol Pharmacol; 2008 Nov; 74(5):1269-77. PubMed ID: 18701617
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Activation of Peroxisome Proliferator-Activated Receptor-β/δ (PPARβ/δ) in Keratinocytes by Endogenous Fatty Acids.
    Zhu B, Zhu X, Borland MG, Ralph DH, Chiaro CR, Krausz KW, Ntambi JM, Glick AB, Patterson AD, Perdew GH, Gonzalez FJ, Peters JM.
    Biomolecules; 2024 May 21; 14(6):. PubMed ID: 38927010
    [Abstract] [Full Text] [Related]

  • 11. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
    Aleshin S, Grabeklis S, Hanck T, Sergeeva M, Reiser G.
    Mol Pharmacol; 2009 Aug 21; 76(2):414-24. PubMed ID: 19483106
    [Abstract] [Full Text] [Related]

  • 12. Gene regulation of CYP4F11 in human keratinocyte HaCaT cells.
    Wang Y, Bell JC, Keeney DS, Strobel HW.
    Drug Metab Dispos; 2010 Jan 21; 38(1):100-7. PubMed ID: 19812349
    [Abstract] [Full Text] [Related]

  • 13. The role of peroxisome proliferator-activated receptor-beta/delta in epidermal growth factor-induced HaCaT cell proliferation.
    Liang P, Jiang B, Yang X, Xiao X, Huang X, Long J, Zhang P, Zhang M, Xiao M, Xie T, Huang X.
    Exp Cell Res; 2008 Oct 15; 314(17):3142-51. PubMed ID: 18625220
    [Abstract] [Full Text] [Related]

  • 14. Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPARbeta/delta to RAR.
    Schug TT, Berry DC, Toshkov IA, Cheng L, Nikitin AY, Noy N.
    Proc Natl Acad Sci U S A; 2008 May 27; 105(21):7546-51. PubMed ID: 18495924
    [Abstract] [Full Text] [Related]

  • 15. Peroxisome proliferator-activated receptor-β/δ inhibits human neuroblastoma cell tumorigenesis by inducing p53- and SOX2-mediated cell differentiation.
    Yao PL, Chen L, Dobrzański TP, Zhu B, Kang BH, Müller R, Gonzalez FJ, Peters JM.
    Mol Carcinog; 2017 May 27; 56(5):1472-1483. PubMed ID: 27996177
    [Abstract] [Full Text] [Related]

  • 16. Cannabidiolic acid activates the expression of the PPARβ/δ target genes in MDA-MB-231 cells.
    Hirao-Suzuki M, Takayuki K, Takiguchi M, Peters JM, Takeda S.
    Arch Biochem Biophys; 2022 Nov 30; 731():109428. PubMed ID: 36228705
    [Abstract] [Full Text] [Related]

  • 17. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D, Bianchi A, Boyault S, Sebillaud S, Koufany M, Francois M, Netter P, Jouzeau JY, Terlain B.
    Arthritis Rheum; 2005 Mar 30; 52(3):759-69. PubMed ID: 15751073
    [Abstract] [Full Text] [Related]

  • 18. Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) inhibits cell growth in a mouse mammary gland cancer cell line.
    Foreman JE, Sharma AK, Amin S, Gonzalez FJ, Peters JM.
    Cancer Lett; 2010 Feb 28; 288(2):219-25. PubMed ID: 19660859
    [Abstract] [Full Text] [Related]

  • 19. Synthesis of isosteric selenium analog of the PPARbeta/delta agonist GW501516 and comparison of biological activity.
    Sharma AK, Sk UH, He P, Peters JM, Amin S.
    Bioorg Med Chem Lett; 2010 Jul 15; 20(14):4050-2. PubMed ID: 20542425
    [Abstract] [Full Text] [Related]

  • 20. Inverse PPARβ/δ agonists suppress oncogenic signaling to the ANGPTL4 gene and inhibit cancer cell invasion.
    Adhikary T, Brandt DT, Kaddatz K, Stockert J, Naruhn S, Meissner W, Finkernagel F, Obert J, Lieber S, Scharfe M, Jarek M, Toth PM, Scheer F, Diederich WE, Reinartz S, Grosse R, Müller-Brüsselbach S, Müller R.
    Oncogene; 2013 Oct 31; 32(44):5241-52. PubMed ID: 23208498
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.